Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246879 · ClinicalTrials.gov registry record · NA
MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases
A NA study of Brain Metastases, sponsored by Duke University.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04246879 is a NA study of Brain Metastases that is active but no longer recruiting, run by Duke University. The registered enrollment target is 25 participants, below the 213-participant average among 67 other Brain Metastases trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04246879, a NA study of Brain Metastases, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).
Conditions Studied
Interventions
- OTHER MRI
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2027-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04246879
The ClinicalTrials.gov registry entry for NCT04246879 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 67 other Brain Metastases trials with a reported enrollment target (88% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Metastases appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT04246879 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04246879 about?
NCT04246879 is a clinical study titled "MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases". The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).
What is the current status of trial NCT04246879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-07-19. Estimated completion is 2027-03-19.
What conditions does trial NCT04246879 study?
This clinical trial studies the following conditions: Brain Metastases.
What interventions are being tested in trial NCT04246879?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT04246879?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04246879 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
RECRUITING · NA
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
RECRUITING · NA
-
REMASTer: REcurrent Brain Metastases After SRS Trial
RECRUITING · NA
-
Development of MRF for Characterization of Brain Tumors After Radiotherapy
RECRUITING · NA
-
MeDex: No Perioperative Dexamethasone in Brain Metastases
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.